Table 1.
Characteristic | N = 66 |
---|---|
Median Age (Range) | 54.5 (21–82) |
Sex | |
Male | 34 (52 %) |
Female | 32 (48 %) |
Diagnosis | |
Primary Intracranial | |
Glioma | |
Glioblastoma | 27 (40.9 %) |
Astrocytoma | 11 (16.7 %) |
Oligodendroglioma | 4 (6.1 %) |
Ependymoma | 1 (1.5 %) |
Unknown low-grade glioma | 1 (1.5 %) |
Meningioma | 3 (4.5 %) |
Pineal Tumor | 1 (1.5 %) |
Schwannoma | 1 (1.5 %) |
Metastatic Post-Resection Cavity | |
Breast | 6 (9.1 %) |
Lung | 6 (9.1 %) |
Colorectal | 2 (3.0 %) |
Cervix | 1 (1.5 %) |
Endometrial | 1 (1.5 %) |
Renal | 1 (1.5 %) |
Radiotherapy Prescription Dose | Median (Range) |
Primary Intracranial | 54 (40–60) Gy |
Metastatic Post-Resection Cavity | 30 (27.5–30) Gy |
Number of Fractions | |
Primary Intracranial | 15 (N = 12; 18.1 %) |
25 (N = 1; 1.5 %) | |
30 (N = 35; 53.0 %) | |
33 (N = 1; 1.5 %) | |
Metastatic Post-Resection Cavity | 5 (N = 17; 25.8 %) |